| SWARM-BOT: A new distributed robotic concept F Mondada, GC Pettinaro, A Guignard, IW Kwee, D Floreano, ... Autonomous robots 17, 193-221, 2004 | 526 | 2004 |
| The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs M Boi, E Gaudio, P Bonetti, I Kwee, E Bernasconi, C Tarantelli, A Rinaldi, ... Clinical Cancer Research 21 (7), 1628-1638, 2015 | 321 | 2015 |
| Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome E Chigrinova, A Rinaldi, I Kwee, D Rossi, PMV Rancoita, JC Strefford, ... Blood, The Journal of the American Society of Hematology 122 (15), 2673-2682, 2013 | 295 | 2013 |
| The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas U Novak, A Rinaldi, I Kwee, SV Nandula, PMV Rancoita, M Compagno, ... Blood, The Journal of the American Society of Hematology 113 (20), 4918-4921, 2009 | 282 | 2009 |
| Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma A Rinaldi, I Kwee, M Taborelli, C Largo, S Uccella, V Martin, G Poretti, ... British journal of haematology 132 (3), 303-316, 2006 | 274 | 2006 |
| Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma D Rossi, S Deaglio, D Dominguez-Sola, S Rasi, T Vaisitti, C Agostinelli, ... Blood, The Journal of the American Society of Hematology 118 (18), 4930-4934, 2011 | 240 | 2011 |
| Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome A Rinaldi, M Mian, E Chigrinova, L Arcaini, G Bhagat, U Novak, ... Blood, The Journal of the American Society of Hematology 117 (5), 1595-1604, 2011 | 217 | 2011 |
| Anaplastic lymphoma kinase in human cancer A Barreca, E Lasorsa, L Riera, R Machiorlatti, R Piva, M Ponzoni, I Kwee, ... Journal of molecular endocrinology 47 (1), R11-R23, 2011 | 166 | 2011 |
| A SNP microarray and FISH‐based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect L Agnelli, L Mosca, S Fabris, M Lionetti, A Andronache, I Kwee, K Todoerti, ... Genes, Chromosomes and Cancer 48 (7), 603-614, 2009 | 155 | 2009 |
| Dynamics in protein translation sustaining T cell preparedness T Wolf, W Jin, G Zoppi, IA Vogel, M Akhmedov, CKE Bleck, T Beltraminelli, ... Nature immunology 21 (8), 927-937, 2020 | 144 | 2020 |
| 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia M Dal Bo, FM Rossi, D Rossi, C Deambrogi, F Bertoni, I Del Giudice, ... Genes, Chromosomes and Cancer 50 (8), 633-643, 2011 | 142 | 2011 |
| Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 D Rossi, S Rasi, S Franceschetti, D Capello, A Castelli, L De Paoli, ... Leukemia 23 (6), 1118-1126, 2009 | 139 | 2009 |
| KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study S Ferrero, D Rossi, A Rinaldi, A Bruscaggin, V Spina, CW Eskelund, ... Haematologica 105 (6), 1604, 2020 | 138 | 2020 |
| PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma M Boi, A Rinaldi, I Kwee, P Bonetti, M Todaro, F Tabbo, R Piva, ... Blood, The Journal of the American Society of Hematology 122 (15), 2683-2693, 2013 | 137 | 2013 |
| Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma A Rinaldi, G Poretti, I Kwee, E Zucca, CV Catapano, MG Tibiletti, F Bertoni Leukemia & lymphoma 48 (2), 410-412, 2007 | 136 | 2007 |
| Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation N Martinez, C Almaraz, JP Vaqué, I Varela, S Derdak, S Beltran, ... Leukemia 28 (6), 1334-1340, 2014 | 127 | 2014 |
| Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma L Agnelli, E Mereu, E Pellegrino, T Limongi, I Kwee, E Bergaggio, ... Blood, The Journal of the American Society of Hematology 120 (6), 1274-1281, 2012 | 127 | 2012 |
| High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome N Delaleu, P Mydel, I Kwee, JG Brun, MV Jonsson, R Jonsson Arthritis & rheumatology 67 (4), 1084-1095, 2015 | 120 | 2015 |
| Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts I Scarfò, E Pellegrino, E Mereu, I Kwee, L Agnelli, E Bergaggio, G Garaffo, ... Blood, The Journal of the American Society of Hematology 127 (2), 221-232, 2016 | 118 | 2016 |
| PQR309 is a novel dual PI3K/mTOR inhibitor with preclinical antitumor activity in lymphomas as a single agent and in combination therapy C Tarantelli, E Gaudio, AJ Arribas, I Kwee, P Hillmann, A Rinaldi, ... Clinical Cancer Research 24 (1), 120-129, 2018 | 115 | 2018 |
